Equity Markets

We present a summary of changes in key Indian & Global equity indices


Nifty 50 Nifty Midcap 100 Nifty Small Cap 100 Dow Jones Indus. Avg S&P 500 Index Nasdaq Composite Index
1 Mth Performance -3.0% -5.3% -10.2% 0.0% 0.0% -2.1%
1 Yr Performance 6.4% 9.7% -0.6% -4.5% -1.7% -12.1%

Source: Bloomberg: Data as on May 31st, 2022

Indian markets continued to witness opposing flows between domestic investors and global investors. While FPIs continued their selling pressure, retail investors continue to remain aggressive buyers both directly as well as via domestic institutions. Broad markets were down with a wide gap in sectoral performances. Sector wise, Financials, FMCG & Auto outperformed while IT, Metals, Energy, Pharma & Realty underperformed Nifty. Global markets too were weak. The month-end data reflects a far better outcome vis a vis the intra-month lows across equity markets.

The Indian Economic data for Q4FY22 & full year FY22 was released. The economy rebounded strongly at 8.7% growth vis-a-vis 6.6% de-growth in FY21. In fact, real GDP is 1.5% higher than that in FY20. This is commendable as contact-intensive services sector (trade, hotel, transport etc) remains a laggard (still below FY20 levels). In terms of nominal GDP, we grew by 19.2% YoY in FY22 vis-a-vis de-growth of 1.4% in FY21. Nominal GDP in absolute terms, stood at Rs 236 lakh crores. The 8.7% real GDP growth re-affirms India’s position as amongst the fastest growing large economies. We expect the trend to continue and meet the projections by IMF, World Bank, etc. of India becoming the 3rd largest economy in this decade. As GDP grows, the per capita GDP growth will accelerate leading to a virtuous cycle of higher consumption, higher tax collection and rising investment by private sector as well as government. Corporate earnings follow GDP growth and so do financial investors. We believe the growth in economy and earnings will lead to India remaining a preferred investment destination for global investors. The headwind of US Fed tightening is perhaps a near-term cloud covering the silver lining of India’s growth path.

Globally, the key worries remain same; Fed Policy to tackle Inflation, impact of Russia-Ukraine war and Covid-19 restrictions in China.

The US Fed has laid out a policy path to tame inflation via quantitative tightening and raising rates as a reversal to its support to markets during Covid-19. US Fed took the policy action of infusing $120 bn every month for over 24 months; since Covid-19 break out in March 2020. In a way, this was Fed’s “SIP” that went in multiple markets (equity, bonds, real estate, commodities, crypto, etc). This led to excess liquidity chasing few assets and with loss-making and very low profit-making companies being excessively valued in the name of long-term growth. Now, as a part of policy reversal, Fed is starting monthly “SWP” from June 1; $47.5 bn for 3 months and then $95 bn for 12 months. The size and scale of the tightening is quite unprecedented and hence one needs to be careful of the risks to valuations.

The Russia-Ukraine war continues with worsening financial implications for inflation, global growth and markets. It has been over 3 months since war commenced and we are yet to see any tangible signs of ceasefire. The longer the war, wider will be implications on energy and food price inflation. Crude has been steady at around $110-120 range hurting many countries and companies.

Covid-19 restrictions in China are creating a supply shortage leading to inflation. A recovery in Covid-19 or some easing in business restrictions would help ease supply and inflation.

Indian economy too, is currently witnessing high inflation and may lead to some deceleration in growth. RBI at its April policy had released growth forecasts for FY23 at 7.2%. Considering the macro uncertainties, RBI may review and revise it at June meeting. Energy imports (Oil, Gas & Coal) constitute a sizeable portion of India’s imports and has implications on current account, inflation, growth as well as BoP. In FY23, RBI has also commenced its path of tightening by announcing a surprise rate hike during the month of May and stated its willingness to take further hikes if required to control inflation. From fiscal policy perspective, government has taken steps of curbing inflation by imposing restrictions on exports so as to improve local availability at lower prices. These acts hurt exporting companies, but end up helping the consuming companies, making some shift in profit pool among sectors and companies.

Looking Ahead

The quick resolution to Russia-Ukraine conflict and Covid-19 in China are pre-dominant variables for global economic stability and financial markets. The US Fed policy normalisation is more likely to impact asset valuation. Globally, the key risk in equity markets is the reversal of the high valuations as the Fed moves ahead on the tightening path. Already, we have seen companies with “poor earnings/cash flows at present but expectations of higher and longer-term growth” being hit more in markets vis-a-vis companies having near-term growth and cash flows. The divergence in performance between NASDAQ & Dow Jones Index illustrates the same. Nasdaq Index represents growth companies, while Dow Jones Index represent value companies generating cash flows in near-term.

For Indian economy and corporates too, the implications are similar. High inflation typically creates margin pressure as well as demand contraction and hence earnings estimates could get downgraded. The Q4FY22 results have been good on an overall basis though the raw material and energy costs have hurt margins for some. However, the real impact is likely to be felt in Q1FY23. Amidst the uncertainties, our investment approach remains focussed on quality companies who are market leaders in their respective industries having least leveraged balance sheets and some pricing power for their products. Challenge to Indian markets is sizable selling by FPIs since October 2021.

Asset allocation to equities creates wealth over long term as growth rewards equity assets. Growth outlook turns volatile at various times due to multiple factors. History has shown that equity assets acquired during volatile times deliver better returns over longer term. We recommend

    1. Conservative investors continue to use systematic investment route and avoid the market timing worries.
    2. Aggressive investors can attempt market timing via lumpsum investments.
    3. Balance investors use “Balanced Advantage route”. This allows fund managers the flexibility of shifting asset allocation and time the market during volatility.




Scheme Strategy - Equity Schemes
  • Mahindra Manulife Multi Cap Badhat Yojana
  • Mahindra Manulife Mid Cap Unnati Yojana
    • This scheme would aim to invest in companies that demonstrate higher earnings growth outlook , potential of rerating  or sectoral leadership position which can take advantage of the India’s growth story. The portfolio will investing in predominantly mid-cap stocks (>65%) apart from some exposure to small and large-cap stocks. The portfolio will have a mix of top-down and bottom-up approach to investing.
  • Mahindra Manulife ELSS Kar Bachat Yojana
    • The portfolio has allocation to stocks across market capitalization and may focus on companies that have the power to take advantage of the opportunities the economy offers. The stocks in the portfolio are likely to have a superior product line, manageable debt and leadership in their respective sectors.
  • Mahindra Manulife Flexi Cap Yojana
    • The Scheme follows top down sector allocation and bottom up stock selection ideas that may benefit based on health of economy. Allocation across marketcaps is a function of economic outlook, domestic liquidity and stage of market cycle. Focus will be on high quality, growth focussed companies available at reasonable valuations.
  • Mahindra Manulife Rural Bharat and Consumption Yojana
    • The portfolio is a concentrated portfolio and aims to have a rural bias and look for opportunities in rural consumption, rural infrastructure and rural lending.
  • Mahindra Manulife Large Cap Pragati Yojana
    • The portfolio is a concentrated portfolio with a top-down approach would be adopted to identify sectors with potential across different periods based on emerging macro trends. In addition, a bottom-up stock selection would also be followed, to identify companies with earnings growth potential, strong balance sheet and good governance.
  • Mahindra Manulife Top 250 Nivesh Yojana
    • The scheme focusses on investing in companies that have demonstrated strong leadership and sustained growth and continue to do so. The portfolio currently has around 53%,38% and 5% of net equity holdings in large, mid and small cap respectively.
  • Mahindra Manulife Focused Equity Yojana
    • The Scheme focuses on maintaining an appropriate diversified portfolio of companies with a medium term perspective. The Scheme follows a top down approach to select sectors and a bottom up approach to pick stocks across the sectors based on the quality of business model and quality of management. Quality of business model and quality of management will be assessed by evaluating past track record and/or future outlook. The selection of companies will be guided by a combination of one or more factors like:
      1. growth opportunities
      2. cash flows generated and ability to finance the growth
      3. management quality to deliver the growth
Scheme Specific Strategies for Hybrid Schemes
  • Mahindra Manulife Equity Savings Dhan Sanchay Yojana

    Equity:

    • Portfolio composition would have preference for growth style of investing.
    • Bottom-up approach would be adopted to identify companies that have ability to scale up, gain market share and/or are present in sunrise/high growth sectors.


    Debt:

    • The Modified duration of the portfolio has decreased to 1.37 years for the debt portion
    • The allocation at the moment has larger allocation towards short tenor quality credits but we intend to have an equal allocation between credits and gilts as we move ahead
  • Mahindra Manulife Hybrid Equity Nivesh Yojana

    Equity:

    • Macro theme of the portfolio will be to identify the status of economy and invest in sectors with potential to outperform
    • Portfolio composition would have preference for companies with potential for earnings upgrade and possible valuation upgrades as well.


    Debt:

    • The Modified duration of the portfolio is around 2.60 years for the debt portion
    • We have now a larger allocation to gilts than credits and may maintain this stance in the near future
  • Mahindra Manulife Balanced Fund Yojana

    Equity:

    • Portfolio composition would have preference for growth style of investing with large cap bias.
    • Bottom-up approach would be adopted to identify companies that have ability to scale up, gain market share and/or are present in sunrise/high growth sectors.


    Debt:

    • The Modified duration of the portfolio is around 2.86 years for the debt portion
    • The duration is built through exposure in 10-year/5-year Gilt
What should an investor do?
For investments in equity oriented products:

  • Our view is that volatility may continue and SIP may be a good way to increase equity market allocations
  • Investors looking to invest for a medium to long period, can consider SIPs or STPs into focused, multicap or hybrid funds based on risk appetite.
  • Investors looking for a better return opportunity and with a suitable risk appetite, may consider part allocation in mid cap fund as well.
Bond And Money Market

We present a matrix detailing movement in few key market rates (domestic and global) and key events:

Parameters 31st May 22 29th Apr 22 31st May 21
RBI Repo Rate % 4.40 4.00 4.00
5Y AAA PSU % 7.43 6.87 6.27
1 year CD % 6.29 5.30 4.15
10Y Gsec % 7.42 7.13 6.02
CPI (%) 7.79 6.95 4.29
IIP (YoY) % 1.85 1.69 22.35
US 10Y % 2.84 2.94 1.59
Dollar Rupee 77.64 76.43 72.61

Source: Bloomberg; Data as on May 31st, 2022

It wasn’t a script meant to be: on May 4th, the RBI governor announced that the MPC had an off cycle meet and the MPC had decided to increase Repo rates by 40 basis points (bps) to 4.40%. The reasons for the off-cycle rate hike was alluded to the rapid rise in inflation and its spread across the global. The RBI also increased the CRR by 50 bps to 4.50% leading to INR 87,000 crores of liquidity withdrawal.

The action of the RBI caught the market off-guard. The short-end of the curve, upto the 1-year segment saw rate increase by around 100 bps and the mid -long segment increased by 40 bps. The benchmark 10-year sovereign rates increased by around 30 bps to close at around 7.40%.

Globally, the geopolitical crisis continued to have a pressure on crude with crude prices increasing by around 10% through the month. With China opening gradually and start of US driving /holiday season, it may keep the pressure on crude oil. However, the silver lining for inflation globally can be the fall of metal and steel prices. Historically, metals have been a lead indicator of slowing inflation and we would keep a close watch on the trajectory of the metal prices.

Looking Ahead
  • While we continue remain apprehensive of a rate rise as we move through the year, we believe the first half of the current financial year may mark the terminal value of the rate rise phenomenon.
  • The possibility of a bear flattening of the yield curve, especially in the 1-5 year-segment remains high with the start of the rate hike cycle
  • We also believe that AAA credit spreads are very tight and the probability of spreads to increase in the near future remains a distinct possibility
  • Liquidity being gradually normalized, the extreme short-end of the yield curve may also remain under pressure
What should an investor do?

  • We believe that the investors with a shorter time horizon of less than one-year may continue investments in ultra-short term and low duration funds
  • Short term fund category may be suitable for investors looking to stay for a time horizon beyond one year with a lower risk volatility
  • For a long investment horizon and with a suitable risk appetite, a small allocation to Dynamic Bond fund merits attention
Scheme strategy – Debt Schemes
  • Mahindra Manulife Low Duration Fund
    • The average maturity is around 216 days
    • The YTM of the portfolio is increased to 5.84 %
    • With our view on Gsec possibly offering better opportunities than Bonds, we derive around 30% of our duration through Gsecs in this fund
    • We would remain skewed in this duration range as the RBI has started the hike cycle
    • Potential Risk Classification (PRC)
      Potential Risk Class Matrix (Maximum risk the Scheme can take)
      Credit Risk Relatively Low (Class A) Moderate (Class B) Relatively High (Class C)
      Interest rate Risk
      Relatively Low (Class I) B-I
      Moderate (Class II)
      RelativelyHigh (Class III)
  • Mahindra Manulife Ultra Short Term Fund
    • The average maturity of the portfolio decreased to around 127 days
    • We will remain in this maturity segment as we move ahead through the next month
    • The YTM of the portfolio is around 5.57 %
    • Potential Risk Classification (PRC)
      Potential Risk Class Matrix (Maximum risk the Scheme can take)
      Credit Risk Relatively Low (Class A) Moderate (Class B) Relatively High (Class C)
      Interest rate Risk
      Relatively Low (Class I) B-I
      Moderate (Class II)
      Relatively High (Class III)
  • Mahindra Manulife Liquid Fund
    • We continue to maintain a healthy mix of certificate of deposits and commercial papers
    • We will attempt to ensure adequate liquidity, safety and accrual
    • Potential Risk Classification (PRC)
      Potential Risk Class Matrix (Maximum risk the Scheme can take)
      Credit Risk Relatively Low (Class A) Moderate (Class B) Relatively High (Class C)
      Interest rate Risk
      Relatively Low (Class I) B-I
      Moderate (Class II)
      Relatively High (Class III)
  • Mahindra Manulife Dynamic Bond Yojana
    • The YTM of the portfolio is around 6.64%
    • The Modified Duration of the portfolio (MD) decreased to around 3 years
    • The Portfolio largely derives it duration from Gilts as we believe that the AAA credit spreads may expand as we move ahead
    • Potential Risk Classification (PRC)
      Potential Risk Class Matrix (Maximum risk the Scheme can take)
      Credit Risk Relatively Low (Class A) Moderate (Class B) Relatively High (Class C)
      Interest rate Risk
      Relatively Low (Class I)
      Moderate (Class II)
      Relatively High (Class III) B-III
  • Mahindra Manulife Short Term Fund
    • The YTM of the portfolio is around 6.49%
    • The Modified duration of the portfolio is around 1.52 years
    • Our portfolio continues to have a large allocation towards gilts, accounting for around 50% the duration as we are wary of the spreads increasing in AAA credits
    • Potential Risk Classification (PRC)
      Potential Risk Class Matrix (Maximum risk the Scheme can take)
      Credit Risk Relatively Low (Class A) Moderate (Class B) Relatively High (Class C)
      Interest rate Risk
      Relatively Low (Class I)
      Moderate (Class II) B-II
      Relatively High (Class III)
Scheme Name Product Suitability Scheme Riskometer Scheme Benchmark Benchmark Riskometers
Mahindra Manulife Multi Cap Badhat Yojana
(Multi Cap Fund - An open-ended equity scheme investing across large cap,mid cap, small cap stocks)
This Product is suitable for investors who are seeking*:
  • Medium to Long term capital appreciation.
  • Investment predominantly in equity and equity related securities including derivatives.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty 500 Multicap 50:25:25 Index TRI
Mahindra Manulife Mid Cap Unnati Yojana
(Mid Cap Fund – An open ended equity scheme predominantly investing in mid cap stocks)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation.
  • Investment predominantly in equity and equity related securities including derivatives of mid cap companies.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty Midcap 150 TRI
Mahindra Manulife ELSS Kar Bachat Yojana
(An open ended equity linked savings scheme with a statutory lock in of 3 years and tax benefit)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty 500 TRI Index
Mahindra Manulife Flexi Cap Yojana
(An open ended dynamic equity scheme investing across large cap, mid cap, small cap stocks)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment in diversified portfolio of equity & equity related instruments across market capitalization
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understand that their principal will be at Very High risk
Nifty 500 Index TRI
Mahindra Manulife Rural Bharat and Consumption Yojana
(An open ended equity scheme following rural india theme)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities including derivatives of entities engaged in and/or expected to benefit from the growth in rural India
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty India Consumption Index TRI
Mahindra Manulife Large Cap Pragati Yojana:
(Large Cap Fund - An open ended equity scheme predominantly investing in large cap stocks)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities including derivatives of large cap companies.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty 100 Index TRI
Mahindra Manulife Top 250 Nivesh Yojana
(Large & Mid Cap Fund- An open ended equity scheme investing in both large cap and mid cap stocks)
This Product is suitable for investors who are seeking*:
  • Long term wealth creation and income
  • Investment predominantly in equity and equity related securities of large and mid cap companies.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty LargeMidcap 250 Index TRI
Mahindra Manulife Focused Equity Yojana
(An open ended equity scheme investing in maximum 30 stocks across market caps (I.e Multi Cap))
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment in equity and equity related instruments in concentrated portfolio of maximum 30 stocks across market capitalziation
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
NSE 500 Index TRI
Mahindra Manulife Equity Savings Dhan Sanchay Yojana
(An open ended scheme investing in equity, arbitrage and debt)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income
  • Investment in equity and equity related instruments, arbitrage opportunities and debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Moderately high risk
Nifty Equity Savings Index TRI
Mahindra Manulife Hybrid Equity Nivesh Yojana
(An open ended hybrid scheme investing predominantly in equity and equity related instruments)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income.
  • Investment in equity and equity related instruments and debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very high risk
CRISIL Hybrid 35+65 Aggressive Index
Mahindra Manulife Balanced Advantage Yojana
(An open ended dynamic asset allocation fund)
This Product is suitable for investors who are seeking*:
  • Capital Appreciation while generating income over medium to long term.
  • Investments in a dynamically managed portfolio of equity and equity related instruments and debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understand that their principal will be at Very high risk
Nifty 50 Hybrid Composite Debt 50: 50 Index TRI
Mahindra Manulife Low Duration Fund
(An open ended low duration debt scheme investing in instruments such that the Macaulay duration of the Portfolio is between 6 months and 12 months(please refer to page no. 33 of SID). A relatively low interest rate risk and moderate credit risk)
This Product is suitable for investors who are seeking*:
  • Regular Income over short term.
  • Investment in debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Moderate risk
CRISIL Low Duration Fund BI Index
Mahindra Manulife Ultra Short Term Fund
(An open ended ultra-short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 3 to 6 months(please refer to page no. 31 of SID). A relatively low interest rate risk and moderate credit risk)
This Product is suitable for investors who are seeking*:
  • Regular Income over short term.
  • Investment in a portfolio of short term debt and money market instruments
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understand that their principal will be at Moderate risk
CRISIL Ultra Short Duration Fund BI Index
Mahindra Manulife Liquid Fund
(An open ended liquid scheme. A relatively low interest rate risk and moderate credit risk)
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in money market and debt instruments
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Low to Moderate risk
CRISIL Liquid Fund BI Index
Mahindra Manulife Dynamic Bond Yojana
(An open ended dynamic debt scheme investing across duration. A relatively high interest rate risk and moderate credit risk)
This Product is suitable for investors who are seeking*:
  • To generate regular returns and capital appreciation through active management of portfolio.
  • Investments in debt & money market instruments across duration.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Moderate risk
CRISIL Dynamic Bond Fund BIII Index
Mahindra Manulife Short Term Fund
(An open ended short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 1 year and 3 years(please refer to page no. 36 of SID). A moderate interest rate risk and moderate credit risk)
This Product is suitable for investors who are seeking*:
  • Income over short to medium term
  • Investment in debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Moderate risk
CRISIL Short Duration Fund BII Index
Disclaimer

The views expressed here in this material are for general information and reading purpose only and do not constitute any guidelines and recommendations on any course of action to be followed by the reader. No representation or warranty is made as to the accuracy, completeness or fairness of the information and opinions contained herein. The views are not meant to serve as a professional guide / investment advice / intended to be an offer or solicitation for the purchase or sale of any Financial product or instrument or mutual fund units for the reader. This material has been prepared on the basis of publicly available information, internally developed data and other sources believed to be reliable. While utmost care has been exercised while preparing this material, Mahindra Manulife Investment Management Private Limited (AMC) does not warrant the completeness or accuracy of the information and disclaimers all liabilities, losses and damages arising out of the use of this information. The data/statistics given in this material are to explain general market trends in the securities market, it should not be construed as any research report/research recommendation. Readers of this material should rely on information / data arising out o their own investigations and advised to seek independent professional advise and arrive at an informed decision before making any investments. Neither Mahindra Manulife Mutual Fund, the AMC nor Mahindra Manulife Trustee Private Limited (formerly known as Mahindra Trustee Company Private Limited), its directors or associates shall be liable for any damages that may arise from the use of the information contained herein.

`

Cno.01262

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.